Cancer Australia launches Lung Cancer Framework

Australia |  News | 0 Comment | 17 Apr, 2018

Cancer Australia has launched a Framework to improve the outcomes and experiences of people affected by lung cancer – the leading cause of cancer death in Australia. The utility of t...Read more

Telix, INSERM, ARRONAX enter into translational research partnership

Australia |  News | 0 Comment | 16 Apr, 2018

Singapore – Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmace...Read more

Australian researchers invent tiny fibre optic probe

Australia |  News | 0 Comment | 13 Apr, 2018

A team of researchers at the University of Adelaide has invented a world-first tiny fibre-optic probe that can simultaneously measure temperature and see deep inside the body. The miniatur...Read more

PSA appoints Belinda Wood as new GM

Australia |  News | 0 Comment | 12 Apr, 2018

Outgoing CEO of the Generic and Biosimilar Medicines Association (GBMA), Belinda Wood has been appointed to the role of General Manager (GM), Policy and Advocacy of the Pharmaceutical Socie...Read more

Australian University research gives hope to thalassemia patients

Australia |  News | 0 Comment | 06 Apr, 2018

Researchers at the University of New South Wales (UNSW) in Sydney, Australia, have used CRISPR gene editing technology to introduce beneficial natural mutations into blood cells to boost pr...Read more

Cellmid inks deal for anti-aging skin brand

Australia |  News | 0 Comment | 04 Apr, 2018

Cellmid Limited announced that it has entered into an agreement with Labo International S.r.l to undertake the exclusive distribution of Fillerina, a market leading Swiss anti-aging skincar...Read more

Biocon gets European nod for its insulin to market globally

Australia |  News | 0 Comment | 28 Mar, 2018

Indian biotech major Biocon said that the biosimilar insulin glargine co-developed with US drug major partner Mylan received approval from the European Commission and the Australian regulat...Read more

Mayne pharma launches generic version of Monodox in Australia

Australia |  News | 0 Comment | 19 Mar, 2018

Australia's Mayne Pharma Group recently announced the launch of  doxycycline monohydrate immediate release (IR) capsules (50mg, 75mg and 100mg) in the United States. Doxycycline ...Read more

Propanc Biopharma Completes Reproduction run for its pancreatic drug

Australia |  News | 0 Comment | 15 Mar, 2018

Propanc Biopharma Inc., a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreat...Read more

Fresenius Medical Care gets recognition by ACHS

Australia |  News | 0 Comment | 15 Mar, 2018

The Australian Council on Healthcare Standards (ACHS), Australia's leading independent authority on healthcare, has recognised the high  standard of care that Fresenius Medical Care pr...Read more

Merck inks deal with Australian biotech firm Immutep

Australia |  News | 0 Comment | 13 Mar, 2018

Australia’s biotech giant Immutep has announced that it has entered into a clinical trial collaboration and supply agreement with Merck & Co to evaluate the combination of Immutep...Read more

Kerry Corning initiates phase 1 trial for narcoleptic drug

Australia |  News | 0 Comment | 13 Mar, 2018

Phase I clinical trials to assess its safety, human tolerance, and pharmacokinetic properties. XW10172 is the first compound that Kerry Corning has independently developed in innovative dru...Read more

Australian scientists to develop blood test for lung cancer

Australia |  News | 0 Comment | 11 Mar, 2018

A team of scientists from the Walter and Eliza Hall Institute of Medical Research in Australia have discovered a unique molecular signature of an aggressive lung cancer called adenocarcinom...Read more

'Cancer is an increasingly important health issue in the APAC region’

Australia |  Influencers | By Aishwarya venkatesh | 0 Comment | 09 Mar, 2018

Globally, the radiopharmaceutical medicine market is expected to reach USD 13.8 billion by 2024, according to a new report by Grand View Research. The market is driven by increasing number ...Read more

Merck snaps up Australian firm Viralytics for $394M

Australia |  News | 0 Comment | 26 Feb, 2018

In  a bid to further broaden its immune-oncology portfolio, Merck has recently acquired Australian firm Viralytics for $394 million. The deal gives Merck access to Viralytics’s i...Read more

Atomo, RPS Diagnostics collaborate to address respiratory infections

Australia |  News | 0 Comment | 23 Feb, 2018

Australian firm Atomo Diagnostics has collaborated with US-based biotechnology company RPS Diagnostics for the development and commercialisation of next-generation FebriDx tests to diagnose...Read more

Zealand Pharma, Uniquest collaborate for gastrointestinal drugs

Australia |  News | 0 Comment | 21 Feb, 2018

The commercialisation company of The University of Queensland (UQ), Australia announced collaboration with Zealand Pharma to identify novel peptide therapeutics inspired by venoms as potent...Read more

Mundipharma acquires Australia's Tolmar; adds Eligard to its portfolio

Australia |  News | 0 Comment | 21 Feb, 2018

Mundipharma recently announced the acquisition of specialist pharmaceutical company, Tolmar Australia , including exclusive distribution rights for the oncology medication Eligard (leuprore...Read more